US Broker Ratings

iRadimed Corporation (IRMD): Investor Outlook on an Innovative Medical Device Leader

iRadimed Corporation (NASDAQ: IRMD), a pioneering player in the healthcare sector, has captured the attention of investors with its robust performance in the medical devices industry...

Tyra Biosciences, Inc. (TYRA): Exploring a 126.63% Upside Potential in the Biotech Arena

For investors eyeing the healthcare sector, particularly within the biotechnology industry, Tyra Biosciences, Inc. (NASDAQ: TYRA) presents a compelling opportunity. With a market capitalization of $752.56..

Akso Health Group (AHG) Stock Analysis: Exploring a Remarkable 415.80% Revenue Growth in the Healthcare Sector

Akso Health Group (NASDAQ: AHG), a dynamic player in the healthcare sector, has captured investor attention with its impressive 415.80% revenue growth. Operating at the intersection..

Stoke Therapeutics, Inc. (STOK) Stock Analysis: A Biotech with Robust Revenue Growth and Analyst Confidence

Stoke Therapeutics, Inc. (NASDAQ: STOK) is making waves in the biotechnology sector with its innovative approach to treating severe genetic diseases. As a company that specializes..

Altimmune, Inc. (ALT): Investor Outlook Reveals 315% Potential Upside in Biotech Innovations

In the ever-evolving landscape of the biotechnology sector, Altimmune, Inc. (NASDAQ: ALT) stands out as a clinical-stage biopharmaceutical company with a compelling narrative and substantial upside..

Eton Pharmaceuticals, Inc. (ETON) Growth Potential: Analyst Consensus Suggests a 61.81% Upside

Eton Pharmaceuticals, Inc. (NASDAQ: ETON) is capturing the attention of investors with its ambitious focus on developing treatments for rare diseases. Based in Deer Park, Illinois,..

Rocket Pharmaceuticals, Inc. (RCKT) Investor Outlook: Analyzing Over 100% Potential Upside

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a dynamic player in the biotechnology sector, is garnering attention from investors due to its ambitious gene therapy programs targeting rare..

Upstream Bio, Inc. (UPB) Stock Analysis: Biotechnology Star with 135% Potential Upside

Investors seeking opportunities in the biotechnology sector might want to turn their attention to Upstream Bio, Inc. (NASDAQ: UPB), a promising clinical-stage biotech company. With a..

Akebia Therapeutics, Inc. (AKBA) Investor Outlook: A Promising 148% Upside Potential Amid Robust Revenue Growth

Akebia Therapeutics, Inc. (NASDAQ: AKBA), a biopharmaceutical company specializing in therapeutics for kidney diseases, presents an intriguing opportunity for investors seeking significant growth potential. With an..

Butterfly Network, Inc. (BFLY) Stock Analysis: Exploring a 42.64% Potential Upside in the Healthcare Sector

Butterfly Network, Inc. (NASDAQ: BFLY) is capturing the attention of investors with its innovative contributions to the medical devices industry. Founded in 2011 and headquartered in..

Maravai LifeSciences Holdings (MRVI) Stock Analysis: Examining a Potential 14.94% Upside in the Biotechnology Sector

Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) stands out as a key player in the biotechnology sector, offering innovative solutions in nucleic acid production and biologics safety..

Valneva SE (VALN) Stock Analysis: A 38.69% Potential Upside Amid Vaccine Innovations

Valneva SE (NASDAQ: VALN), a French biotechnology firm specializing in the development and commercialization of prophylactic vaccines, is capturing investor attention with its robust pipeline and..

Bicycle Therapeutics (BCYC) Stock Analysis: A High-Risk, High-Reward Prospect with 206% Upside Potential

Bicycle Therapeutics plc (NASDAQ: BCYC) is a United Kingdom-based biotech company that has captured the attention of investors with its innovative approach to developing a new..

Iovance Biotherapeutics, Inc. (IOVA) Stock Analysis: Unpacking a 315% Potential Upside

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) stands out in the biotechnology sector with a remarkable 315% potential upside, according to analyst ratings. This potential is particularly noteworthy..

Xencor, Inc. (XNCR) Stock Analysis: A Biotech Innovator with 108% Potential Upside

Xencor, Inc. (NASDAQ: XNCR) is making waves in the biotechnology sector with its innovative approach to developing engineered monoclonal antibodies for a range of challenging diseases,..

Neuropace, Inc. (NPCE) Stock Analysis: Unpacking the 58.77% Potential Upside for Healthcare Investors

Neuropace, Inc. (NPCE) has captured the attention of healthcare investors, particularly those focusing on the medical device sector. Operating out of Mountain View, California, Neuropace is..

Nutex Health Inc. (NUTX)

⚠️ No article content returned.

..

REGENXBIO Inc. (RGNX) Stock Analysis: Exploring a 132.69% Potential Upside in Biotechnology

REGENXBIO Inc. (NASDAQ: RGNX), a clinical-stage biotechnology company headquartered in Rockville, Maryland, is making waves in the healthcare sector, particularly in the field of gene therapy...

Embecta Corp. (EMBC): Unpacking the 17.87% Potential Upside Amidst Robust Dividend Yield

Embecta Corp. (NASDAQ: EMBC), a stalwart in the healthcare sector, is capturing investor attention with a significant potential upside of 17.87% and a compelling dividend yield..

Auna SA (AUNA) Stock Analysis: Healthcare Giant’s 93% Upside Potential Sparks Investor Interest

Auna S.A. (AUNA), a prominent player in the healthcare sector, is capturing investor attention with its substantial upside potential. Based in Luxembourg, Auna operates a network..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds